Log In
Print
BCIQ
Print
Print this Print this
 

Diquas, diquafosol tetrasodium ophthalmic solution 3%

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
Description3% ophthalmic solution formulation of uridine 5'-triphosphate (UTP) natural P2Y2 ligand
Molecular Target Purinergic receptor P2Y G protein-coupled 2 (P2RY2) (P2Y2)
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationDry eye
Partner

Allergan Inc.; Santen Pharmaceutical Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today